Yield10 Bioscience (YTEN) Revenue & Revenue Breakdown


OverviewForecastFinancialsChartTranscripts

Yield10 Bioscience Revenue Highlights


Latest Revenue (Y)

$60.00K

Latest Revenue (Q)

$450.00K

Main Segment (Y)

Grant

Main Geography (Y)

UNITED STATES

Yield10 Bioscience Revenue by Period


Yield10 Bioscience Revenue by Year

DateRevenueChange
2023-12-31$60.00K-86.67%
2022-12-31$450.00K-26.71%
2021-12-31$614.00K-23.15%
2020-12-31$799.00K-0.87%
2019-12-31$806.00K44.96%
2018-12-31$556.00K-41.10%
2017-12-31$944.00K-18.55%
2016-12-31$1.16M-55.32%
2015-12-31$2.59M-7.36%
2014-12-31$2.80M-48.09%
2013-12-31$5.39M-87.25%
2012-12-31$42.32M2869.54%
2011-12-31$1.43M218.08%
2010-12-31$448.00K-68.56%
2009-12-31$1.43M-8.36%
2008-12-31$1.55M-7.61%
2007-12-31$1.68M-63.33%
2006-12-31$4.59M65.05%
2005-12-31$2.78M-24.39%
2004-12-31$3.68M54.34%
2003-12-31$2.38M19.82%
2002-12-31$1.99M-

Yield10 Bioscience generated $60.00K in revenue during NA 2023, up -86.67% compared to the previous quarter, and up 10.79% compared to the same period a year ago.

Yield10 Bioscience Revenue by Quarter

DateRevenueChange
2024-06-30$450.00K50.00%
2024-03-31$300.00K400.00%
2023-12-31$60.00K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$60.00K-31.03%
2022-12-31$87.00K-21.62%
2022-09-30$111.00K7.77%
2022-06-30$103.00K-30.87%
2022-03-31$149.00K-1.97%
2021-12-31$152.00K65.22%
2021-09-30$92.00K-47.13%
2021-06-30$174.00K-11.22%
2021-03-31$196.00K0.51%
2020-12-31$195.00K-4.41%
2020-09-30$204.00K-7.69%
2020-06-30$221.00K23.46%
2020-03-31$179.00K27.86%
2019-12-31$140.00K-37.50%
2019-09-30$224.00K-29.56%
2019-06-30$318.00K156.45%
2019-03-31$124.00K-8.15%
2018-12-31$135.00K77.63%
2018-09-30$76.00K-73.33%
2018-06-30$285.00K375.00%
2018-03-31$60.00K-42.31%
2017-12-31$104.00K-53.36%
2017-09-30$223.00K-23.89%
2017-06-30$293.00K-9.57%
2017-03-31$324.00K-4.99%
2016-12-31$341.00K-27.91%
2016-09-30$473.00K-83.06%
2016-06-30$2.79M313.78%
2016-03-31$675.00K36.09%
2015-12-31$496.00K-30.04%
2015-09-30$709.00K-4.70%
2015-06-30$744.00K15.35%
2015-03-31$645.00K-24.65%
2014-12-31$856.00K35.44%
2014-09-30$632.00K-45.98%
2014-06-30$1.17M9.45%
2014-03-31$1.07M20.11%
2013-12-31$890.00K4.09%
2013-09-30$855.00K-49.88%
2013-06-30$1.71M-12.20%
2013-03-31$1.94M39.08%
2012-12-31$1.40M107.27%
2012-09-30$674.00K-26.98%
2012-06-30$923.00K-97.65%
2012-03-31$39.32M8857.18%
2011-12-31$439.00K-6.40%
2011-09-30$469.00K145.55%
2011-06-30$191.00K-41.41%
2011-03-31$326.00K188.50%
2010-12-31$113.00K145.65%
2010-09-30$46.00K-57.80%
2010-06-30$109.00K-39.44%
2010-03-31$180.00K-12.20%
2009-12-31$205.00K-66.45%
2009-09-30$611.00K75.57%
2009-06-30$348.00K33.33%
2009-03-31$261.00K-34.59%
2008-12-31$399.00K13.68%
2008-09-30$351.00K-12.47%
2008-06-30$401.00K-0.74%
2008-03-31$404.00K-54.50%
2007-12-31$888.00K-

Yield10 Bioscience generated $450.00K in revenue during Q2 2024, up 50.00% compared to the previous quarter, and up 750.00% compared to the same period a year ago.

Yield10 Bioscience Revenue Breakdown


Yield10 Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Grant$614.00K

Yield10 Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 21: Grant (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Grant--$87.00K$111.00K$103.00K$149.00K$152.00K$92.00K$174.00K$196.00K$195.00K$204.00K$221.00K$179.00K$140.00K$224.00K$318.00K$124.00K$135.00K$76.00K
License$450.00K$300.00K------------------

Yield10 Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License (100.00%).

Yield10 Bioscience Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
CANADA--$39.00K$2.01M$1.88M
UNITED STATES$60.00K$450.00K$575.00K$646.00K$806.00K

Yield10 Bioscience's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (100.00%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18
UNITED STATES$450.00K$300.00K-$60.00K$111.00K$103.00K$149.00K$92.00K$174.00K$157.00K$109.00K$204.00K$154.00K$179.00K$140.00K$224.00K$318.00K$124.00K$135.00K-
CANADA--------$492.00K$540.00K-$440.00K-$570.00K---$368.00K--
Grant----$87.00K---------------

Yield10 Bioscience's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (100.00%).

Yield10 Bioscience Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
NTRNutrien$29.59B$5.36B
CTVACorteva$17.23B$2.33B
MOSMosaic$13.70B$2.82B
LVROLavoro$9.35B$2.55B
ICLICL Group$7.65B$1.72B
CFCF Industries$6.63B$1.37B
FMCFMC$4.49B$1.07B
SMGScotts Miracle-Gro$3.55B$1.20B
AVDAmerican Vanguard$579.37M$118.31M
BHILBenson Hill$473.34M$33.77M
BIOXBioceres Crop Solutions$419.80M$84.00M
IPIIntrepid Potash$279.08M$57.55M

YTEN Revenue FAQ


What is Yield10 Bioscience’s yearly revenue?

Yield10 Bioscience's yearly revenue for 2023 was $60K, representing a decrease of -86.67% compared to 2022. The company's yearly revenue for 2022 was $450K, representing a decrease of -26.71% compared to 2021. YTEN's yearly revenue for 2021 was $614K, representing a decrease of -23.15% compared to 2020.

What is Yield10 Bioscience’s quarterly revenue?

Yield10 Bioscience's quarterly revenue for Q2 2024 was $450K, a 50.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $300K, a 400.00% increase from the previous quarter (Q4 2023), and a 400.00% increase year-over-year (Q1 2023). YTEN's quarterly revenue for Q4 2023 was $60K, a 100.00% increase from the previous quarter (Q3 2023), and a -31.03% decrease year-over-year (Q4 2022).

What is Yield10 Bioscience’s revenue growth rate?

Yield10 Bioscience's revenue growth rate for the last 3 years (2021-2023) was -90.23%, and for the last 5 years (2019-2023) was -92.56%.

What are Yield10 Bioscience’s revenue streams?

Yield10 Bioscience's revenue streams in c 21 are Grant

What is Yield10 Bioscience’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Yield10 Bioscience was Grant. This segment made a revenue of $614K, representing 100.00% of the company's total revenue.